B
Braidwell’s Keros Therapeutics KROS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,894,439
| Closed | -$30M | – | 74 |
|
2024
Q4 | $30M | Buy |
1,894,439
+1,187,199
| +168% | +$18.8M | 0.89% | 42 |
|
2024
Q3 | $41.1M | Sell |
707,240
-274,969
| -28% | -$16M | 1.16% | 36 |
|
2024
Q2 | $44.9M | Buy |
982,209
+244,830
| +33% | +$11.2M | 1.41% | 30 |
|
2024
Q1 | $48.8M | Sell |
737,379
-381,582
| -34% | -$25.3M | 1.57% | 27 |
|
2023
Q4 | $44.5M | Sell |
1,118,961
-238,348
| -18% | -$9.48M | 1.63% | 22 |
|
2023
Q3 | $43.3M | Buy |
1,357,309
+213,444
| +19% | +$6.8M | 1.37% | 25 |
|
2023
Q2 | $46M | Buy |
+1,143,865
| New | +$46M | 1.5% | 21 |
|